Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CEMATRIX Announces $5.1 Million in New Contract Awards
-
ZyVersa Therapeutics CEO Issues Mid-year Shareholder Letter Highlighting Recent Corporate Developments and R&D Progress
-
Amneal Announces Proposed Refinancing of Existing Credit Agreement, including Private Offering of Senior Secured Notes Due 2032
-
Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results
-
Lifeist Wellness Expands Mikra’s Mind-First Product Portfolio with Three New Performance-Focused Formulations
-
Jeffs’ Brands Appoints Accomplished Capital Markets and Experience M&A Professional as Chief Executive Officer
-
Jeffs’ Brands Appoints Accomplished Capital Markets and Experience M&A Professional as Chief Executive Officer
-
FLEXJET RAISES $800 MILLION EQUITY INVESTMENT FROM INVESTMENT GROUP LED BY L CATTERTON
-
Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesine’s Protection of Neurons and Synapses in Alzheimer’s Disease
-
Stallion Uranium Refines Coyote Target with Highly Conductive Anomalies from Ground EM Survey
-
Q-Gold Resources engages FHB Consulting Services LLC to update the Resource Estimate for Quartz Mountain
-
Proposed Consolidation of Shares
-
Ocugen, Inc. Announces New Appointments to Retina Scientific Advisory Board & Executive Leadership Team
-
Domestic Metals Begins Trading on OTCQB
-
Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline
-
Ocugen, Inc. Announces New Appointments to Retina Scientific Advisory Board & Executive Leadership Team
-
SAB BIO Announces Oversubscribed $175 Million Private Placement
-
NextGen Digital Announces Treasury Strategy to Incorporate Crypto Assets, Acquires $1.0 Million in Bitcoin
-
Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline
-
Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary
-
Nasdaq Verafin Announces Launch of its Agentic AI Workforce, Delivering a Step Change in AML Compliance Efficiency
-
Universal Safety Products, Inc. Announces Notice of Noncompliance with NYSE American Continued Listing Standards due to delayed filing of Form 10-K
-
Ambiq Announces Launch of Initial Public Offering
-
Digi Power X Announces $15 Million Registered Direct Offering of Common Stock
-
iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right
-
TidyCoin Launches to Turn Crypto Clutter Into Deflationary Gold With a First-of-Its-Kind Burn Ecosystem
-
Form 8.3 - [MARLOWE PLC - 18 07 2025] - (CGWL)
-
Form 8.3 - Marlowe plc - Octopus Investments
-
ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia
-
Global energy security concerns driving investment in clean energy and tech, and Canadians can benefit: report
-
Osisko Development Secures US$450 Million Financing Facility to Develop the Cariboo Gold Project
-
WAVLINK Unveils the Ultimate Productivity Docking Station: New DisplayLink® Pro DL-7400 Delivers 8K Resolution and Quad-Display Support for Power Users and Enterprise
-
DTC, a Codan Company, Expands Strategic Footprint in Asia-Pacific with Appointment of Colonel Brady Crosier as VP of Business Development
-
National Comprehensive Cancer Network® (NCCN®) Guidelines Recommend Monoclonal Antibodies for COVID-19 Prevention in People with Cancer; New Data Published in JAMA Oncology Underscore Severe Impact
-
Gilat to Report Second Quarter 2025 Results on Wednesday, August 6th
-
HBT Financial, Inc. Announces Second Quarter 2025 Financial Results
-
Kraig Biocraft Laboratories Successfully Completes Lab-to-Field Transition for Three New Spider Silk Production Strains
-
SchoolAI's Deep Canvas Integration Helps Educators Reach Every Student, Every Day
-
SchoolAI's Deep Canvas Integration Helps Educators Reach Every Student, Every Day
-
Rogers Announces Upsizing and Results of its Cash Tender Offers for Canadian Dollar Debt Securities
-
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor A
-
Rogers Announces Results and Upsize of its Cash Tender Offers for Eight Series of U.S. Dollar Debt Securities
-
Monte Rosa Therapeutics Announces First Subjects Dosed in Phase 1 Study of MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases
-
Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient
-
SmartPayNet Expands Payment Services to Over 100 Countries, Strengthening Its Global Presence in High-Risk Payments
-
Beneficient Appoints Tom Hicks as Chairman and James Silk as Interim Chief Executive Officer
-
Tonix Pharmaceuticals Announces the Launch of the “Move Fibro Forward” Campaign to Bring Awareness to Individuals Impacted by Fibromyalgia
-
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
-
DIFI Consortium Calls for Presentations & Announces Date of 2025 Workshop at MILCOM
-
Viva Gold to Present at the Metals & Mining Virtual Investor Conference July 23, 2025
